Premium
Palliation and breast cancer
Author(s) -
Yip ChengHar
Publication year - 2017
Publication title -
journal of surgical oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.201
H-Index - 111
eISSN - 1096-9098
pISSN - 0022-4790
DOI - 10.1002/jso.24560
Subject(s) - medicine , randomized controlled trial , breast cancer , overall survival , metastatic breast cancer , cancer , surgery , retrospective cohort study , survival rate , oncology , systemic therapy
Metastatic breast cancer is an incurable disease. With improvement in systemic therapy, survival has improved over the past few years. Removing the primary tumor has shown improved survival in retrospective studies, but this may be due to selection bias. The first reported randomized controlled trial (RCT) from India showed no difference in survival with surgery. However another RCT from Turkey showed that a select group of patient with bone‐only metastases have a survival benefit.